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Summary One hundred and fifty patients with cutaneous malignant melanoma, in clinical stage I at
diagnosis, were studied prospectively to determine the lymph nodal metastatic pattern of the disease, and to
find that combination of clinical and pathological variables best predictive of the probability of its occurrence
when combined in a linear logistic regression equation based upon a model by Cox. Details of the general
pattern of melanoma recurrence are included to provide a necessary background to the nodal metastatic
study. Of 66 patients showing melanoma recurrence in 48 (19 males and 29 females) it took the form of
lymph nodal metastasis. Of these 50% showed lymph nodal metastasis within 1.1 years of the primary
operation and 90% within 3.8 years. Nineteen clinical and pathological variables were tested for association
with lymph nodal metastasis, 15 of which showed a significant association and in 7 of these the association
was highly significant (P_0.0001). All 19 variables were included in the logistic regression analysis, 6 being
selected as providing the best regression 'goodness of fit' and of these 'maximum tumour thickness (Breslow'
and 'sex' emerged as the dominant variables. It is concluded that the analysis described provides surgeons,
oncologists, and pathologists with a practical method to assess the likelihood in an individual patient of
melanoma recurrence to regional lymph nodes. This should enable surgery or other adjunctive therapeutic
regimens to be selected at an early stage.
The importance of lymph nodal metastasis to
cutaneous malignant melanoma (MM) patients may
be considered from the following viewpoints: (1) the
development of disseminated disease; (2) treatment;
(3) prognosis and (4) survival. With regard to the
first and last of these Weidner et al. (1976) have
stated that in terms of prognosis the early spread of
tumour into regional lymph nodes is considered the
most critical event. This view was supported by
Veronesi et al. (1971) who observed that in about
85% of their cases involvement of the regional
lymph nodes was an index of the spread of the
disease and that metastases beyond the regional
nodes had probably occurred but were not
detectable. Concerning the second and third of the
above points, the provision of an accurate
assessment of the probability of nodal recurrence in
clinical Stage I patients (tumour still confined to the
primary site) shortly following their primary
operation would provide the clinician with a means
of selecting an optimal therapeutic regimen with the
possibility of halting the spread of the disease and
inducing cure or a prolonged survival.
Prediction of the probability of lymph nodal
metastasis in clinical Stage I MM patients has
followed three main lines of study. In the first,
selected clinical or pathological variables, either
singly or in pairs have been correlated with regional
nodal metastasis. For example the work of Clark et
al. (1969) showed a high degree of correlation
between the level of tumour microinvasion
according to anatomical landmarks and the
incidence of lymph nodal metastases, and also that
of Breslow (1975) who showed that the incidence of
lymph nodal metastasis from cutaneous MM in
clinical Stage I patients was directly proportional to
the maximum tumour thickness. In the second
approach, illustrated by the work of Schmoeckel &
Braun-Falco (1978), a prognostic index was
developed based upon the maximum tumour
thickness multiplied by the number of mitoses per
mm2. In the third, mathematical analyses first
introduced by Polk & Linn (1971) and later used in
one or other of the various forms of multiple
regression analysis (multivariate analysis) were used
generally with survival as the dependent variable.
An exception is seen in the work of Day et al.
(1982a,b) who used a Cox proportional hazard
analysis to determine that group of clinical and
pathological variables best predictive of MM
metastasis to bony or visceral sites.
The present study is a logical continuation of
that previously reported by Eastwood & Baker
(1983). Its primary aim is to determine by means of
a logistic regression analysis, based upon a Cox
model, that combination of clinical and
pathological variables providing the most reliable
estimate of the probability of lymph nodal
Correspondence: J. Eastwood.
Received 21 September 1983; accepted 20 March 1984.36 J. EASTWOOD & T.G. BAKER
metastasis occurring in a given patient. A secondary
aim is to establish the pattern of tumour recurrence
with special reference to regional lymph nodal
metastasis in the group of patients studied.
Patients and methods
Clinical and pathological data concerning the 150
patients with cutaneous MM, whose recurrence
pattern is described, have already been reported
together with the majority of definitions and
techniques used (Eastwood & Baker, 1983). Thus
only a few additional definitions, histological
techniques, and modifications to analytical
techniques related to recurrence of the tumour are
included here.
Patients
Sixty-six (44%) of the 150 patients studied by
Eastwood & Baker (1983) showed recurrent disease
and formed the basis of the present work, particular
attention being given to those patients showing
regional lymph nodal metastasis.
Definitions
With the exception of the lymph drainage area
allocated to the popliteal lymph nodes, the
definition of regional or first station nodes followed
that given in the 'Manual for Staging of Cancer,
1977' (American Joint Committee for Cancer
Staging and End-Results Reporting). Concerning
the lymph drainage area of the popliteal nodes we
have followed Das Gupta & McNeer (1964) and
regarded the inguinal nodes as the first station
nodes for the lower limb. Clinical staging of patients
was according to the M.D. Anderson Hospital
system described by Smith (1976) and others.
The following definitions were not included in
Part I of this report: (i) a local recurrence was one
occurring within 3cm of the primary lesion; (ii)
satellite tumours were intradermal tumour deposits
occurring within the same range, the primary
tumour still being present; (iii) scar recurrences were
tumour deposits occurring along the line of the
surgical scar, in the skin graft, or at the graft
margins; (iv) intransit deposits were tumour deposits
occurring more than 3cm from the primary site in
the line of lymphatic drainage; while (v) central
deposits were tumour deposits at other sites within
the body, for example, liver, lung, brain, bone, or
disseminated throughout the body. Details
concerning the primary treatment of the patients
studied and the method of follow-up are given in
Part I (Eastwood & Baker, 1983). In essence, unless
contraindicated by anatomical or other
considerations, primary treatment was surgical and
consisted of wide excision of the tumour followed
by a skin graft. None of the 66 patients showing
lymph nodal metastasis were subject to elective
lymphadenectomy or other form of adjunctive
therapy in the period prior to nodal recurrence.
Histopathology
Lymphadenectomy specimens were photographed
prior to dissection and microscopic examination.
Individual lymph nodes were subsequently fixed in
10% formol-saline and were either step-sectioned
(small nodes) or a minimum of four blocks were
taken from planes parallel to the major axis.
Sections were routinely stained with H & E,
Goldner's modification of the Masson trichrome
stain, the Gomori technique for reticulin, and the
Masson-Fontana stain for melanin. All sections
were examined by the same histopathologist (J.E.).
Statistical methods
Chi square methods (with Yates' correction when
appropriate) were used to test frequency differences
in the contingency tables and the association
between pairs of variables. Regional nodal
metastatic rates were calculated according to the
maximum utilization of the life table method
(Cutler & Ederer, 1958), the table being modified
into a morbidity table by replacement of the table
headings "alive at beginning of interval" and "died
during interval" by "no nodal metastasis during
interval' and "first nodal metastasis during interval".
Patients dying without showing nodal metastasis
were classified as "lost to follow-up during interval".
A stepwise linear regression analysis based upon
Cox's (1970) model was used (the reasons for using
this model rather than Cox's later (1972) model are
stated in an addendum to Part I of this study: see
Eastwood & Baker, 1983) the analysis being carried
out on the Cyber/720 computer at the University of
Bradford using the BMDP PLR program
(Engleman, 1979). Of the two variants of the
program MLR and ACE, the later was used as
previous work had shown that the MLR variant
was very expensive in computer time when the
number of terms to be analysed was large (>10).
The ACE variant is less reliable than the MLR and
uses an asymptotic covariance matrix to estimate
the regression. It is, however, considerably faster
making the computation of large problems
practical.
Results
Tumour recurrence
Sixty-six (44%) of the 150 patients studied showed
recurrence of their disease. Details of the sex andRECURRENCE OF CUTANEOUS MELANOMA 37
Table I Type of first recurrence, patient's sex, interval from primary operation to first
of interval in 66 clinical Stage I MM patients at diagnosis
recurrence and range
TYpe of recurrence
No. of
patients
Sex ("O)
Mean intervalfriom
Total primarY surgery to
(0o) recurrence (nmonths)
Range of interval
(motiths)
Scar
Intransits
Regional lymph nodal
Distant lymph nodal
Central
Simultaneous (two or more)
Other (e.g. second primary)
M 2 (3)
F 7(11)
M 1 (1)
F 6 (9)
M 11(17)
F 23(35)
M I (1)
F 0
M I(1)
F 4(6)
M 4(6)
F 5(8)
M 0
F 1(1)
Grand total
9(14)
7(11)
34(51)
1 (1)
5 (8)
9(14)
1 (1)
25.5
18.3
23.2
7.2
18.0
31.1
90.1
2.7- 77.0
3.8- 71.0
3.8-122.0
0.0
2.8- 24.8
3.1- 96.0
0.0
66(100)'
"Percentages rounded to nearest whole number.
first MM recurrence of these patients are shown in
Table 1.
Metastasis to lymph nodes
At the close of study, in 73O0 (48/66) of patients
showing recurrence it took the form of lymph nodal
metastasis, and in 35 of these it provided the first
clinical evidence of recurrent disease. Relative to the
total numbers of each sex at risk (36 males and 114
females) the proportions were 53% and 25% respect-
ively. The mean age of all patients showing nodal
metastasis was 52.9 years (s.d. 16.6) c.f., that of
males 55.7+ 13.1 years; and of females 51.0+ 18.6
years. The incidence of lymph nodal metastasis by
decade and sex is shown in Figure 1. Relative to the
total numbers of each sex at risk a male
predominance was present in the 5th, 6th, 7th, and
8th decades, and a female predominance in the 3rd,
4th, and 9th.
When related to the number of patients of each
sex at risk nodular malignant melanoma (NMM)
was superficial spreading melanoma (SSM)
accounted for 280,, of regional lymph nodal
metastasis in males compared to 18o" in females.
Table II shows lymph nodal metastasis in
10 * Female
-C] Male
Cu
0.
-0
E
z
0-9 1019 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+
Age (y)
Figure 1 Age of patient at diagnosis relative to lymph nodal metastasis and sex.38 J. EASTWOOD & T.G. BAKER
Table II Pattern of lymph nodal involvement according to type, patient's sex, mean interval from primary
treatment to nodal recurrence and range of interval in 48 MM patients in clinical Stage I at diagnosis.
No. of Mean intervalfrom
patients Total primary surgery to Range ofinterval
Type ofrecurrence Sex (%) (%) recurrence (months) (months)
Regional nodes only M 12(25) 34(71) 23.3 1.7-122.0 F 22(46)
Distant nodes only M 1 (2) 1 (2) 7.2 0.0 F 7.0.
Nodal metastases preceded M 0 1 (2) 64.8 0.0
by scar recurrence F 1 (2)
Nodal metastases preceded M 1 (2) 4 (8) 21.1 8.9- 37.3
by transit recurrence F 3 (6)
Nodal metastases preceded M 2 (4)
by scar and intransit F ° 2 (4) 14.4 7.3- 21.5
recurrences
Nodal metastases coincident M 3 (6)
with other forms of F 3 (6) 6(13) 27.7 3.1- 96.0
recurrence
Grand total 48(100)a
aPercentages rounded to nearest whole number.
relation to the general pattern of MM recurrence,
the sex of the patients, and the interval and range in
months from primary tumour directed surgery to
first clinical detection of lymph nodal involvement.
Regional lymph nodal metastasis was the form of
first recurrence most commonly observed and distal
nodal metastasis the least common.
In 34 of the 48 patients showing lymph nodal
metastasis recurrent MM had not previously been
diagnosed. In 3 (9%) the primary tumour had arisen
in the head and neck region, in 5 (15%) in the
upper extremity, in 7 (20%) in the trunk region, and
in 19 (56%) in the lower extremity. In this last
group the primary lesion had been situated between
the knee and the foot in 17 (15%) of the patients.
The cumulative proportions of patients showing
lymph nodal metastasis are shown in Figure 2. Of
all patients developing nodal metastasis 50% did so
within 1.1 years of the primary operation and 90%
within 3.8 years. The corresponding figures for
males were 0.51 years and 1.5 years and for females
2.1 years and >5 years.
Of patients showing lymph nodal metastasis 19
(39%) showed a further recurrence with 11 (23%)
showing central MM deposits within a year
following lymphadenectomy. The remainder showed
other forms of recurrence at intervals of up to nine
years following lymphadenectomy and in three
patients regional nodal metastasis was followed by
further nodal metastasis within 5 years.
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Figure 2 Cumulative incidence of first lymph nodal
metastasis in 48 patients (19 males and 29 females)
calculated from the time of primary tumour directed
surgery. (-) males; (x) females; (0) males and
females.
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Associations between single variables and lymph
nodal metastasis
Table III shows 15 variables found to be
significantly associated with regional lymph nodal
metastasis and lists a further 4 in which a
significant degree of association was not reached.
Logistic regression analysis of variables and
probability oflymph nodal metastasis
Table IV shows the group of predictor variables
selected by the ACE variant of the BMDP PLR
program as providing the best "goodness of fit" to
the logistic regression equation, with lymph nodal
Table III Significant associations found between lymph nodal metastasis and 15
of the nineteen potential predictor variables tested.
Parameter compared X2 df P
Sex of patient 9.1702 1 <0.01
Site of primary lesion (H & N, UE, T, LE)' 7.9205 3 <0.05
Tumour cross-sectional profile 19.8183 2 <0.0001
Height above skin surface 21.5640 3 <0.0001
Maximum tumour diameter (< or > than 10mm) 4.3227 1 <0.05
Tumour ulceration 12.4258 2 <0.002
Maximum tumour thickness (Breslow) 24.5532 3 <0.0001
Level of microinvasion (Clark) 18.7750 3 <0.001
Actinic degeneration of dermal collagen 5.0046 1 <0.05
Tumour cell heterogeneity 7.8286 2 0.02
Tumour cell nucleoli (prominent/not prominent) 6.0407 1 <0.05
Tumour giant cells 31.2127 3 <0.0001
Tumour cell pleomorphism 17.4579 2 <0.01
Tumour cell mitotic activity 20.1610 2 <0.0001
Host reaction (cell) strength 7.6405 2 <0.05
The following parameters were tested but a significant association could not be
demonstrated between them and lymph nodal metastasis: age at diagnosis (> or
< than 50 years); predominant tumour cell type; vascular invasion; and tumour
type (Clark)
'H & N-head and neck, UE-upper extremities, T-trunk, LE-lower
extremities.
Table IV Variables selected for prediction of lymph nodal metastasis, within
5-years of the primary operation, by the BMDP PLR "Ace" stepwise logistic
regression program (Engleman 1979)
Variable Coefficient S.E. Coeff/S.E.
Maximum tumour thickness 0.266 0.151 1.760
Patient's sex -2.032 0.607 -3.349
Tumour height above skin surface
(1) 1.230 1.062 1.159
(2) 1.263 0.653 1.935
(3) -1.549 0.657 -2.358
Tumour cell pleomorphism
(1) 2.175 0.850 2.558
(2) -0.104 0.537 -0.193
Tumour cell mitotic acticity
(1) 1.449 0.634 2.286
(2) -0.760 0.600 - 1.267
Host reaction cell strength
(1) -2.403 0.750 -3.202
(2) -0.719 0.579 -1.214
Goodness of fit x2=48.820; df= 84; P value=0.999.40 J. EASTWOOD & T.G. BAKER
metastasis within five years of the primary tumour
directed operation as the dependent variable. Table
V shows the estimated correlation matrix in the
final model.
Figure 3 shows the percentage of correct
classifications of outcome as a function of various
points on the scale of computed probabilities.
Discussion
The characteristic feature of multivariate analysis is
the consideration of a set of n objects, on each of
which are observed the values of P variables. The
set of objects may be complete or it may be a
sample from a larger set. The variables may be
continuous or discontinuous, and themselves may
be a subset from a larger group (Kendall, 1975).
The multivariate techniques, all of which are
multiple regression methods, involve a linear
function of the independent or prognostic variables.
Details of multiple regression techniques are to be
found in the work of Armitage (1977) and
illustrations of practical applications in that of Lee
(1980).
The advantage of multiple regression analysis lies
in the fact that the method can be used not only to
identify risk factors but also to predict the
probability of occurrence of a selected dependent
variable, in the present work that of lymph nodal
metastasis within a given period of time following
primary operation. This probability can also serve
as an index of risk. All 6 predictor variables selected
by the model show significant association with
lymph nodal metastasis and with 3 (maximum
tumour thickness, height above skin surface, and
tumour cell mitotic activity) the association was
highly significant (P<0.0001) (Table III). All show
a significant association with maximum tumour
thickness and there are many significant
associations between other pairs within the 6 (see
Table II, Eastwood & Baker, 1983).
The purpose of multiple regression analysis, in
this study, is to find that combination of variables
best predictive of the desired outcome. Day et al.
(1982b) have shown that other combinations of
variables may predict the outcome as well or better
than the combination selected by the initial Cox
regression analysis. This occurs when one or more
variables not selected by the primary analysis are
correlated with one or more variables selected by
that analysis, a situation that occurs in the present
study. They refer to this situation as the "alternative
model phenomena" and state that it may explain
apparent discrepant results obtained by various
groups when the Cox proportional hazards analysis
is used. Although the earlier Cox model was used in
the present study we observed in our earlier work
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Figure 3 Percentage of correct classifications at various points on the scale of computed probabilities of
outcome relative to patients showing lymph nodal metastasis.
(Eastwood & Baker, 1983) that variants of the
BMDP PLR program based upon the 1970 Cox
model selected different series of variables as
producing the best regression "goodness of fit", a
situation that may well have arisen as a result of
association between variables in the manner
described by Day et al. (1982b). A knowledge of this
possibility is of the greatest importance in seeking
an explanation of apparently anomalous results.
The percentage of correct classifications of
outcome at various points on the probability scale
are shown in Figure 3. Of interest is the rapid fall
in accuracy of prediction at the beginning and end
of the scale compared with a level of accuracy of
about 85% over its greater part. The cause of this is
not known but may be the result of a smaller
number of patients showing these low and high
probabilities of outcome. A graph of this type has
importance in that it gives the probability that a
given prediction of outcome concerning an
individual patient is a correct prediction. It also has
the merit that it shows in a simple form whether or
not one regression is providing more accurate
predictions than another over the whole of the
probability scale. The percentage of accurate
predictions given at each point on the probability
of outcome scale being the final criterion upon
which the value of a given regression model of this
type can be judged and compared.
The emergence of maximum tumour thickness as
the dominant predictor variable in the six selected
to form the regression caused little surprise; a
correlation between increasing melanoma thickness
and risk of regional nodal metastases having been
observed by many workers, (e.g. Breslow, 1975 &
1978; Holmes et al., 1976; Balch et al., 1979; and
Roses et al., 1982). The choice of sex as the second
partial regression coefficient may reflect the marked
difference in incidence and rate of lymph nodal
metastasis observed between males and females
(Table II, Figure 2) with the result that they are
forming two significantly different groups in this
respect.,This view is supported by Weidner et al.
(1976) who found lymph nodal metastasis to be
significantly increased in males, a finding in accord
with that of the present study. Of the remaining
variables selected as partial regression coefficients,
tumour cell mitotic activity showed a high degree of
association with lymph nodal metastasis
(P<0.0001) and also a high degree of association
with maximum tumour thickness (Eastwood &
Baker, 1983) suggesting a certain degree of
interaction between the two. Likewise, height of the
tumour above the skin surface showed a high
degree of association with both maximum tumour
thickness (Eastwood & Baker, 1983) and with
lymph nodal metastasis (P<0.0001). The host
reaction (cell) strength and tumour cell
pleomorphism were both significantly associated
with maximum tumour thickness (P<0.05:
Eastwood & Baker, 1983) and with lymph nodal
metastasis (P<0.05). A feature that emerges from
this study is that the primary variables selected as
dominant, namely, tumour thickness and to a lesser
extent sex of patient, show concordance with other
regression analyses using survival for a given period
as the dependent variable.
Details regarding the group of patients forming
the study (Tables I, II, and Figure 3) are included
to illustrate the clinical and pathological
background to this study, to show the relationship
of lymph nodal metastasis to other forms of MM42 J. EASTWOOD & T.G. BAKER
recurrence, and to temporal and other aspects of
lymph nodal metastasis. Much of the information
included in the section is confirmatory of work
done elsewhere and will not, therefore be discussed
here.
Finally, it is concluded that the linear logistic
regression equation developed in the present work
will provide a useful means of assisting the surgeon
or oncologist, by providing an index in the form of
a probability, relative to an individual patient, of
the likelihood of occurrence of regional lymph
nodal metastasis. Such a probability can be
provided shortly following the primary tumour
directed surgery and can give guidance as to the
desirability of further surgery e.g.
lymphadenectomy, or other form of post-primary
adjunctive therapy given at an early stage of the
disease when the tumour load is relatively low and
maximum effect might reasonably be expected.
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Appendix Examples of prognostic forecasts for "A" a patient who showed regional
lymph nodal metastases 37.7 months after primary surgery and "B" a patient who
was free from all clinical evidence of MM recurrence 9.3 years after primary surgery
Covariants and values Coefficient x variable value
T. Maximum tumour thickness 0.266 x 2.40 Aa
0.266 x 1.44 Bb
Coefficient x Design variable
S. Patient's sex
male 2.032
female -2.032 A&B
E. Elevation above skin surface
1. 0.00mm -0.944
2. to 1.99mm -1.549 B
3. 2.00 to 3.99mm 1.263 A
4. . than 4mm 1.230
P. Tumour cell pleomorphism
1. mild 2.071
2. moderate -0.104 B
3. marked 2.175 A
M. Tumour cell mitotic activity
1. <1 fig./5 h.p.f. (Gp. 1) 0.689
2. >1 fig./5 h.p.f. to 1 fig./h.p.f.
(Gp. 2) -0.760 B
3. > 1 fig./h.p.f. (Gp. 3) 1.449 A
H. Host reaction (cell) strength
1. weak -3.122
2. moderate -0.719 A
3. strong -2.403 B
aThe letters "A" and "B" indicate the variant
respectively.
values of patients A and B
Calculations
Patient "A"
P=ex/1 +ex, where x=0.266T+(-2.032)+ 1.263+2.175+ 1.449+(-0.719)T
(maximum thickness) for patient A=2.40mm. Therefore P=0.94, thus this patient
has a 94% chance of regional lymph nodal metastasis within five years of the primary
operation. A similar calculation for patient B indicates that he has a <11% chance
of lymph nodal metastasis during the same period.RECURRENCE OF CUTANEOUS MELANOMA 43
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